# Moleculin, LLC: Form D filings

Moleculin, LLC, a pharmaceuticals company in Houston, TX, filed 10 Form D notices with the SEC between 2011 and 2014. The latest, on October 16, 2014, reports $1.4 million sold of a $2 million offering to 36 investors.

Find out what Moleculin, LLC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20Moleculin%2C%20LLC%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=Moleculin%2C%20LLC&page=%2Fdata%2Fform-d%2Fcompany%2Fmoleculin-llc-1514912)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20Moleculin%2C%20LLC%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=Moleculin%2C%20LLC&page=%2Fdata%2Fform-d%2Fcompany%2Fmoleculin-llc-1514912)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in Texas](https://specstream.ai/data/form-d/state/texas): 4,800 rows, by operating companies, filed since November 1, 2024, $128, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/state/texas
- [Form D filings in Pharmaceuticals](https://specstream.ai/data/form-d/industry/pharmaceuticals): 346 rows, by operating companies, filed since November 1, 2024, $17.30, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/pharmaceuticals

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 1225 NORTH LOOP WEST, SUITE 725, Houston, TX, 77008
- Phone: 713-953-7676 X 232
- Industry: Pharmaceuticals
- Entity type: Limited Liability Company
- Incorporated in: Texas
- Revenue range: Decline to Disclose
- Exemptions claimed: Rule 505
- SEC identifier (CIK): 1514912

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Oct 16, 2014 | Amendment | $2,000,000 | $1,382,783 | $617,217 | 36 | May 14, 2014 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1514912/000151491214000004/0001514912-14-000004-index.htm) |
| Oct 2, 2014 | Amendment | $2,000,000 | $782,783 | $1,217,217 | 24 | May 14, 2014 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1514912/000151491214000003/0001514912-14-000003-index.htm) |
| May 23, 2014 | Amendment | $2,000,000 | $682,984 | $1,317,016 | 21 | May 14, 2014 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1514912/000151491214000002/0001514912-14-000002-index.htm) |
| May 16, 2014 | New notice | $2,000,000 | $491,010 | $1,508,990 | 13 | May 14, 2014 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1514912/000151491214000001/0001514912-14-000001-index.htm) |
| Jun 14, 2013 | Amendment | $2,019,116 | $2,019,116 | $0 | 64 | Apr 22, 2013 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1514912/000151491213000003/0001514912-13-000003-index.htm) |
| May 21, 2013 | Amendment | $2,018,116 | $1,877,657 | $140,459 | 66 | Apr 22, 2013 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1514912/000151491213000002/0001514912-13-000002-index.htm) |
| Apr 24, 2013 | New notice | $2,000,000 | $1,527,465 | $472,535 | 59 | Apr 22, 2013 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1514912/000151491213000001/0001514912-13-000001-index.htm) |
| Aug 22, 2012 | New notice | $3,250,000 | $3,184,757 | $65,243 | 61 | Apr 9, 2012 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1514912/000151491212000002/0001514912-12-000002-index.htm) |
| Dec 14, 2011 | Amendment | $5,000,000 | $4,490,309 | $509,691 | 8 | Mar 3, 2011 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1514912/000151491211000003/0001514912-11-000003-index.htm) |
| Mar 11, 2011 | New notice | $4,000,000 | $1,165,000 | $2,835,000 | 8 | Mar 3, 2011 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1514912/000151491211000002/0001514912-11-000002-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| Walter V Klemp | Executive Officer, Director |  |
| Michael George Clinard | Director |  |
| Robert H Conrad | Director |  |
| Stephen George Drake | Director |  |
| J. George Gumulka | Director |  |
| Donald V Picker | Executive Officer, Director |  |
| Lori H Bisson | Executive Officer, Director |  |

## Other pharmaceuticals companies in Texas that filed recently

- [LUCIER PHARMACEUTICALS INC](https://specstream.ai/data/form-d/company/lucier-pharmaceuticals-inc-2158290) offering · Oct 13, 2026
- [FibroBiologics, Inc.](https://specstream.ai/data/form-d/company/fibrobiologics-inc-1958777) $1.2 million · Oct 13, 2026
- [Eos SENOLYTIX, Inc.](https://specstream.ai/data/form-d/company/eos-senolytix-inc-2129803) $750,000 · Aug 27, 2026

[Every Form D from the week of Oct 13, 2014](https://specstream.ai/data/form-d/week/2014-10-13) · [All recent filings in Texas](https://specstream.ai/data/form-d/state/texas) · [All recent Pharmaceuticals filings](https://specstream.ai/data/form-d/industry/pharmaceuticals)

Read from SEC EDGAR. Amount sold is what Moleculin, LLC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).